# AI Discovery Report: MedTech Solutions

## 1. Company Overview

### Company Profile

| Field | Detail |
| --- | --- |
| Company | MedTech Solutions |
| Industry | Healthcare -- specialty clinic chain |
| Size | ~500 employees |
| Revenue | ~$80M annually |
| IT Team | 12 people |
| Infrastructure | Hybrid on-premises and AWS |
| Engagement Trigger | CEO directive to "use AI to modernize operations" |

### Industry Context

MedTech Solutions operates in the mid-market healthcare provider segment. Specialty clinic chains at this scale face margin pressure from payer negotiations, rising labor costs, clinician burnout, and increasing patient expectations for digital experiences. Competitors are increasingly adopting AI for clinical documentation, patient communication, and revenue cycle optimization. Organizations that digitize and adopt AI for operational efficiency gain measurable advantages in clinician productivity, patient throughput, and revenue capture.

### Competitive AI Landscape

Healthcare competitors are actively deploying:
- Ambient clinical documentation (Nuance DAX, Abridge, Nabla)
- Digital patient intake platforms (Phreesia, Yosi Health)
- AI-assisted medical coding (Fathom, Codametrix)
- Patient communication automation (Luma Health, Artera)
- Prior authorization automation (Cohere Health, Infinitus)

MedTech Solutions' continued use of paper-based intake places them behind industry norms and creates an urgent modernization imperative.

### Regulatory Landscape

| Regulation | Impact on AI Initiatives |
| --- | --- |
| HIPAA | All AI systems touching PHI require BAAs, encryption, access controls, audit trails. HIPAA-eligible cloud services required. |
| HITECH Act | Breach notification obligations extend to AI systems processing PHI. |
| 21st Century Cures Act | Information blocking rules apply to AI systems handling health data. |
| FDA | Clinical diagnostic AI may require clearance; operational AI (intake, coding, scheduling) generally exempt. |
| State health data laws | Depend on clinic locations -- must inventory. |

---

## 2. AI Maturity Assessment

### Dimension Scores

| Dimension | Weight | Score | Stage | Key Evidence |
| --- | --- | --- | --- | --- |
| Data | 25% | 1.5 | Ad Hoc | Paper-based intake; data likely siloed across paper, EHR, billing; no data catalog; quality issues from manual entry |
| Infrastructure | 20% | 2.0 | Transitioning | Hybrid on-prem/AWS; partial cloud adoption; no MLOps; API capability unknown |
| Talent | 20% | 1.5 | No AI Skills / Emerging | 12-person IT team likely has no AI/ML engineers; possible basic analytics; no AI training program |
| Governance | 20% | 1.5 | None / Reactive | No AI policy; HIPAA compliance exists but no AI-specific governance; shadow AI risk |
| Culture | 15% | 2.5 | Curious / Supportive | CEO actively seeking AI; budget available; but paper processes suggest historically slow adoption |

### Aggregate Score

```
Aggregate = (1.5 * 0.25) + (2.0 * 0.20) + (1.5 * 0.20) + (1.5 * 0.20) + (2.5 * 0.15) = 1.75
```

**Overall Maturity: 1.75 / 5.0 -- Foundation Stage**

### Gap Analysis

The highest-scoring dimension is Culture (2.5), driven by CEO sponsorship. All other dimensions score 1.5-2.0, creating a pattern of "high culture, low foundations." The organization wants AI but lacks the data, talent, and governance to execute.

**Primary bottleneck: Data (1.5, weight 25%)**. Paper-based intake means the most operationally valuable data is not digital. This blocks any AI initiative that requires structured patient data. Digitizing intake is both an AI opportunity and a prerequisite for future AI.

**Secondary bottlenecks: Talent (1.5) and Governance (1.5)**. No internal AI capability means every initiative requires external support. No AI governance in a HIPAA environment creates regulatory risk.

### Maturity-Engagement Alignment

At 1.75 (Foundation stage), the engagement approach must:
1. Prioritize digitization and data foundations alongside quick AI wins
2. Use buy-not-build approaches that minimize infrastructure and talent requirements
3. Establish governance before deploying AI tools in clinical workflows
4. Include change management -- moving from paper to digital is a significant organizational shift
5. Build internal capability progressively rather than assuming client self-sufficiency

---

## 3. Stakeholder Findings

*Note: Stakeholder interviews have not yet been conducted. The following captures known information and frames the interview plan.*

### Executive Perspective

**Known**: CEO wants to "use AI to modernize operations." Budget exists but is unspecified. CTO meeting scheduled for next week.

**To validate**:
- CEO's specific success criteria and timeline expectations
- Budget range commitment
- CTO alignment with CEO vision
- Previous digitization or automation attempts and outcomes
- Executive willingness to champion change through the organization

### Department Pain Points (Hypothesized, to validate)

| Department | Hypothesized Pain Points | Validation Needed |
| --- | --- | --- |
| Clinical Operations | Paper intake bottleneck, documentation burden, referral tracking | Operations manager interview |
| Revenue Cycle | Coding errors, claim denials, prior auth burden, revenue leakage | Billing manager interview |
| Front Desk | Manual data entry, phone-based scheduling, patient check-in delays | Frontline staff interviews |
| Clinical Staff | Documentation time, information lookup, care coordination friction | Clinician interviews |
| IT | System maintenance load, integration challenges, security/compliance burden | CTO interview |

### Technical Landscape (Known and hypothesized)

**Known**:
- Hybrid on-prem/AWS infrastructure
- 12-person IT team
- Paper-based patient intake

**To determine**:
- EHR/EMR system and version (critical for integration planning)
- AWS services in use and BAA status
- API architecture and integration capabilities
- Existing enterprise AI tool licenses
- Shadow AI usage
- Data warehouse / analytics infrastructure

### Frontline Insights (To be gathered)

Critical to understand:
- Actual time spent on paper intake process (per patient, per day)
- Clinician documentation time per patient
- Front desk staff time on manual data entry and phone scheduling
- Error rates from paper processes
- Attitudes toward technology change at the frontline level

---

## 4. Risk Assessment

### Identified Red Flags

| Red Flag | Severity | Status | Mitigation |
| --- | --- | --- | --- |
| Vague budget | Medium | To resolve in CEO interview | Get bracket commitment before detailed scoping |
| Paper processes in 2026 (potential deeper issue) | Medium-High | To investigate | Ask about previous digitization attempts; assess root cause |
| No AI governance in HIPAA environment | High | Presumed | Establish AI use policy and governance before any deployment |
| CEO-CTO alignment (potential risk) | Medium | To validate in CTO call | Listen for tension; broker alignment if needed |
| IT team capacity constraints | Medium | To assess in CTO call | Recommend SaaS/managed solutions; include resource requirements in proposals |
| No GenAI risk plan | Medium | Presumed | Include GenAI risk assessment in governance setup |

### Positive Indicators

| Indicator | Significance |
| --- | --- |
| Active CEO sponsorship | Most important success factor for AI initiatives |
| Budget availability (even if vague) | Removes the most common blocker |
| AWS already in place | HIPAA-eligible cloud infrastructure reduces barrier |
| Clear, concrete pain point (paper intake) | Obvious quick win that everyone can support |
| Meaningful organizational scale (500 employees, clinic chain) | Solutions scale across locations for multiplied ROI |
| AI-rich industry vertical | Extensive proven use cases and vendor solutions |

---

## 5. Opportunity Matrix

### Quick Wins (High Impact, High Feasibility)

| # | Opportunity | Impact | Feasibility | Build/Buy | GenAI vs ML | Agent Potential | Phase |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | Digital Patient Intake with AI | 5 | 4 | Buy | Hybrid | Low-Medium | 1 |
| 2 | Ambient Clinical Documentation | 5 | 4 | Buy | GenAI | Medium | 1 |
| 3 | Patient Communication Automation | 4 | 4 | Buy | Rules + GenAI | High | 1 |

**Opportunity 1 -- Digital Patient Intake**: Replace paper forms with a digital intake platform. Eliminates manual data entry, reduces transcription errors, improves patient experience, and -- critically -- creates the digital data foundation for all downstream AI. Buy solution (Phreesia, Yosi Health, or EHR-native). 30-60 day pilot. This is both the highest-impact quick win and a strategic prerequisite.

**Opportunity 2 -- Ambient Clinical Documentation**: AI scribe for patient encounters. Saves clinicians 2-3 hours/day on documentation. Buy solution (Nuance DAX, Abridge, Nabla). 30-60 day pilot with 3-5 clinicians. Highest clinician satisfaction impact.

**Opportunity 3 -- Patient Communication Automation**: AI-powered appointment reminders, pre-visit instructions, rescheduling. Reduces no-shows 5-15%, frees front desk staff. Buy solution (Luma Health, Artera). 30-45 day deployment. Strong agent potential in Phase 2.

### Strategic Bets (High Impact, Lower Feasibility)

| # | Opportunity | Impact | Feasibility | Build/Buy | GenAI vs ML | Agent Potential | Phase |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 4 | Automated Medical Coding | 5 | 3 | Buy | Hybrid | Medium-High | 2 |
| 5 | Prior Authorization Automation | 4 | 3 | Buy | GenAI-heavy | High | 2 |
| 6 | Scheduling Optimization | 3 | 3 | Buy | Traditional ML | Low-Medium | 2-3 |

### Fill-ins and Deprioritized

| # | Opportunity | Impact | Feasibility | Build/Buy | GenAI vs ML | Agent Potential | Phase |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 7 | Quality Reporting Automation | 2 | 4 | Check Licensed / Buy | Rules | Low | 1 (if already licensed) |
| 8 | Clinical Knowledge Base | 3 | 3 | Build or Buy | GenAI (RAG) | Medium | 3 |
| 9 | Diagnostic Imaging AI | 3 | 1 | Buy (if ever) | Traditional ML | Low | Not in scope |

---

## 6. Recommended Roadmap

### Phase 1: Foundation and Quick Wins (Month 1-3)

**Goal**: Demonstrate value, build momentum, establish foundations

**Workstreams**:
- Digital Patient Intake: Vendor selection (weeks 1-3), pilot at one clinic (weeks 4-8), assess and plan expansion (weeks 9-12)
- Ambient Clinical Documentation: Vendor evaluation and clinician selection (weeks 1-4), pilot with 3-5 clinicians (weeks 5-10), gather feedback and measure impact (weeks 11-12)
- Patient Communication Automation: Deploy across clinics (weeks 1-6), optimize messaging and workflows (weeks 7-12)
- AI Governance: Develop AI use policy, establish AI vendor review process, address shadow AI (weeks 1-4)
- Data Assessment: Map all data sources, assess EHR integration capabilities, document data quality (weeks 1-6)

**Milestones**:
- Week 4: AI use policy published; intake vendor selected; ambient scribe vendor selected
- Week 8: Digital intake live at pilot clinic; ambient scribe pilot active
- Week 12: Phase 1 metrics collected; decision point for Phase 2

**Success Metrics**:
- Patient intake time reduced by 50%+
- Manual data entry hours reduced by 70%+
- Clinician documentation time reduced by 40%+ for pilot participants
- No-show rate reduced by 5-10%
- Zero HIPAA incidents related to new AI tools

**Estimated Investment**: $150K-$300K (consulting + platform licensing + integration)

### Phase 2: Expand and Operationalize (Month 3-6)

**Goal**: Scale proven approaches, begin strategic initiatives, build internal capability

**Workstreams**:
- Expand Phase 1 deployments to all clinic locations
- Begin AI-assisted medical coding pilot
- Evaluate and select prior authorization automation vendor
- Internal AI capability building: training for IT team, potential data analyst hire
- Governance maturation: model monitoring processes, expanded AI policy

**Milestones**:
- Month 4: Phase 1 tools deployed across all clinics
- Month 5: Medical coding pilot active
- Month 6: Prior auth vendor selected; Phase 2 review and Phase 3 planning

**Success Metrics**:
- Phase 1 tools achieving target metrics at scale across all clinics
- Coding accuracy improved by 20%+ in pilot
- Internal team demonstrating growing AI capability

**Estimated Investment**: $200K-$400K

### Phase 3: Scale and Differentiate (Month 6-12)

**Goal**: Enterprise-scale AI with measurable competitive advantage

**Workstreams**:
- Scale medical coding and prior auth automation to production across all clinics
- Deploy scheduling optimization
- Add agent capabilities: patient communication agent, prior auth agent
- Evaluate advanced use cases (clinical knowledge base, cross-clinic analytics)
- Assess and hire for permanent AI capability (data engineer, AI/ML specialist)

**Milestones**:
- Month 8: Coding automation live across clinics
- Month 10: Prior auth agent in pilot
- Month 12: Full year review; AI maturity re-assessment (target: 2.5-3.0)

**Success Metrics**:
- Revenue recovery from improved coding: 2-5% improvement
- Prior auth processing time reduced by 40%+
- Provider utilization improved by 10%+
- AI maturity score improved from 1.75 to 2.5+

**Estimated Investment**: $300K-$600K

### Dependencies

- Phase 1 digital intake must precede Phase 2 coding automation (coding accuracy depends on digital documentation quality)
- AI governance must be established before any production deployment
- EHR API capabilities constrain integration timelines for all opportunities
- Budget approval at each phase gate

### Decision Points

| Gate | Timing | Decision | Criteria |
| --- | --- | --- | --- |
| Phase 1 Review | Month 3 | Proceed to Phase 2? | Quick win metrics achieved; no critical red flags materialized; budget confirmed for Phase 2 |
| Phase 2 Review | Month 6 | Proceed to Phase 3? | Scale metrics achieved; coding pilot showing promise; internal capability growing |
| Annual Review | Month 12 | Year 2 strategy | Re-assess maturity; define Year 2 roadmap based on progress |

---

## 7. Investment Summary

| Phase | Timeline | Investment Range | Expected Annual Return | Key Deliverables |
| --- | --- | --- | --- | --- |
| Phase 1 | Month 1-3 | $150K-$300K | $400K-$800K | Digital intake, ambient docs, patient comms, governance |
| Phase 2 | Month 3-6 | $200K-$400K | $500K-$1.5M | Scale Phase 1, coding pilot, prior auth evaluation |
| Phase 3 | Month 6-12 | $300K-$600K | $800K-$2M+ | Coding/PA at scale, scheduling, agent capabilities |
| **Total Year 1** | **12 months** | **$650K-$1.3M** | **$1.7M-$4.3M** | **Full operational AI modernization** |

*Returns are based on healthcare industry benchmarks and assume successful adoption. Conservative estimates used. Actual returns depend on clinic count, patient volume, specialty mix, and organizational adoption.*

---

## Appendices

### A: Interview Plan
See stakeholder-discovery.md for detailed interview guides with role-specific questions for CTO, CEO, Operations, Revenue Cycle, and Frontline staff.

### B: Competitive AI Landscape
Key competitors deploying: ambient documentation (Nuance DAX, Abridge), digital intake (Phreesia), AI coding (Fathom, Codametrix), patient communication (Luma Health, Artera), prior auth (Cohere Health). See company-briefing.md for details.

### C: Technology Assessment
Detailed assessment pending CTO interview. Known: hybrid on-prem/AWS, 12-person IT team, paper-based intake. Critical unknowns: EHR system, API architecture, data warehouse status, existing AI licenses.

### D: Regulatory Considerations
HIPAA is the primary regulatory constraint. All AI tools touching PHI require BAAs, encryption, access controls, and audit trails. FDA clearance may apply to clinical diagnostic AI but not to operational AI (intake, coding, scheduling, communication). See company-briefing.md and industry-playbooks.md (Healthcare section) for detailed regulatory analysis.
